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Abstract 
EEF1E1-BLOC1S5 is a long non-coding RNA that 
derives from the read-through transcription between 
the neighboring EEF1E1 and BLOC1S5 genes. This 
review collects the data on DNA/RNA and the 
diseases where it is involved. 
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Identity 
Other names: EEF1E1-BLOC1S5 readthrough, 
EEF1E1-MUTED, lnc-EEF1E1-2 




EEF1E1-BLOC1S5 was identified for the first time 
by Prakash and colleagues in 2010 (Prakash et al, 
2010). It starts at 8,013,567 nt and ends at 8,102,595 
nt from pter with a length of 89,029 bp. It counts 7 
exons and the current reference sequence is 
NC_000006.12.  
Near to the genomic sequence of EEF1E1-
BLOC1S5 there is a strong promoter transcriptional 
element that is located at +1.0 kb. Enhancer 
transcriptional elements are located at +38.2 Kb and 
at +18.1 Kb respectively. 
Figure. 1. EEF1E1-BLOC1S5 lncRNA.  The figure shows the locus on chromosome 6 for EEF1E1-BLOC1S5 (reworked from 
https://www.ncbi.nlm.nih.gov/gene; http://grch37.ensembl.org; www.genecards.org) 
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Transcription 
EEF1E1-BLOC1S5 counts 2,992 bp and it is a long 
non-coding RNA with reference sequence 
NR_037618.1. It derives from the read-through 
transcription between the neighboring EEF1E1 
(eukaryotic translation elongation factor 1 epsilon 1) 
and MUTED (muted homolog) genes on 
chromosome 6. MUTED gene, alias BLOC1S5 
(biogenesis of lysosomal organelles complex 1 
subunit 5), is a component of BLOC-1 (biogenesis of 
lysosome-related organelles complex 1) complex 
that is involved in the biogenesis of organelles like 
melanosomes and platelet-dense granules.  
It is a chimeric RNA, i.e. an RNA with a sequence 
derived from two genes and its transcriptional and 
post-transcriptional regulations could be the same as 
those of the other known-genes (He et al, 2018).  
It was not possible to find experimentally a protein 
product for this chimeric RNA (Fagerberg et al, 
2014), although in some databases is reported a 
theoretical protein product of 151 amino acids, with 
a predicted weight of 17,02 kDa and isoelectric point 




EEF1E1-BLOC1S5 is a candidate for nonsense-
mediated mRNA decay (NMD) because it is unlikely 
to produce a protein product. 
Protein 
Expression 
EEF1E1-BLOC1S5 ncRNA is transcribed (but not 
translated) widely in human tissues and normal cells. 
In memory B cells, it was found that the EEF1E1-
BLOC1S5 is downregulated in the early gene 
expression (Day3-Day 0) following seasonal  
 
trivalent influenza vaccination in older individuals 
(Haralambieva et al, 2016) 
Implicated in 
Top note 
LncRNAs are nowadays considered as emerging key 
regulators of cellular processes and they are often 
aberrantly expressed in various diseases (Kumar et 
al, 2019).  
EEF1E1-BLOC1S5 is not been still well-
characterized, i.e. it is still unclear its physiologic 
role in the cell and its involvement in diseases when 
its expression is altered, however it is involved in 
some genomic translocations with the creation of 
several fusion genes (Table.1). 
Prostate cancer 
Two genomic translocations were found in prostate 
cancer samples derived from patients, i.e. the 
t(6;17)(p24;p12) EEF1E1-BLOC1S5/NCOR1 and 
the t(6;12)(p24;p13) EEF1E1-BLOC1S5/ZNF384 
(Robinson et al., 2015).  
The t(6;17)(p24;p12) EEF1E1-BLOC1S5/NCOR1 
is originated by the fusion of EEF1E1-BLOC1S5 
gene at 5'-end with "nuclear receptor corepressor 1" 
(NCOR1) gene at 3' end while the t(6;12)(p24;p13) 
EEF1E1-BLOC1S5/ZNF384 NCOR1 is originated 
by the fusion of EEF1E1-BLOC1S5 gene at 5'-end 
with "zinc finger protein 384" ( ZNF384) gene at 3'. 
There are no data about the respective chimeric 
transcripts or proteins and the role of these genomic 
alterations is still unknown. 
Cystic fibrosis 
EEF1E1-BLOC1S5 is found to be over-expressed in 
cystic fibrosis (CF) airway tissues respect control 
tissues and it may play an important role in the 
pathophysiology of CF lung disease. However, 
further studies are needed to understanding its exact 
role in this disease (Kumar et al, 2019). 
 
 






6p25.1 6p24.3 t(6;6)(p24;p25) Translocation Cancer (?) - 1 
EEF1E1-BLOC1S5 EEF1E1 BLOC1S5 6p24.3 6p24.3 
Readthrough 
transcription 


















ZNF384 6p24.3 12p13.31 t(6;12)(p24;p13) Translocation Cancer Prostate - 2 
Table.1 EEF1E1-BLOC1S5 rearrangements: translocations and fusion genes  (reworked from: http://www.tumorfusions.org; 
https://mitelmandatabase.isb-cgc.org/; http://quiver.archerdx.com; http://atlasgeneticsoncology.org//Bands/6p24.html#references: 
https://fusionhub.persistent.co.in/home.html). [ (?) ] unknown; [ 1 ] Campbell et al, 2020; [ 2 ] Robinson et al, 2015; [ - ] no 
reference 
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